Immunochromatography devices, methods and kits
View Patent ↗A membrane-based assay device, methods and kits for determining the presence or quantity of an analyte in a test sample are provided. The immunochromatographic device comprises a membrane having a capture antibody bound thereto at a test zone, wherein the capture antibody is capable of binding with an analyte, in particular a Z-AAT protein present in a sample from a PiZ gene carrier.
1. An immunoassay device comprising:
i) a membrane having a Z-AAT protein capture area defined by a capture antibody specific for Z-AAT protein immobilized thereto;
ii) a sample application area and a flow path from the sample application area to the Z-AAT protein capture area; and
iii) a conjugate structure located in the flow path, wherein the conjugate structure comprises a detection reagent specific for the Z-AAT protein, the detection reagent being mobile or mobilizable;
wherein the capture antibody is selected from the group consisting of monoclonal antibody LG96 produced by hybridoma cells deposited under Accession No. DSM ACC3092, and monoclonal antibody MG97 produced by hybridoma cells deposited under Accession No. DSM ACC3093; and
wherein the detection reagent is a detector antibody selected from the group consisting of monoclonal antibody LG96 produced by hybridoma cells deposited under Accession No. DSM ACC3092, and monoclonal antibody MG97 produced by hybridoma cells deposited under Accession No. DSM ACC3093.
2. The device of claim 1 , wherein the presence or amount of a Z-AAT protein in a fluid sample can be determined by formation of a complex between the capture antibody and the Z-AAT protein that may be present in the fluid sample.
3. The device of claim 1 , wherein the immunoassay device is an immunochromatograhic device comprising the membrane having the capture antibody bound thereto at a test zone, wherein a conjugate structure is fluidly coupled to the membrane at a proximal end, and wherein the detector antibody has a reporter moiety conjugated thereto.
4. The device of claim 3 , wherein the conjugate structure is a conjugate pad that partially overlays the membrane at the proximal end of the membrane.
5. The device of claim 3 , further comprising a blood separation system for receiving the sample, wherein the blood separation system is fluidly coupled to the conjugate structure.
6. The device of claim 5 , wherein the blood separation system partially overlays the conjugate pad.
7. The device of claim 5 further comprising a distal structure fluidly coupled to the membrane at a distal end of the membrane, wherein the distal structure provides sufficient flow-through of the sample from the proximal to the distal end of the membrane.
8. The device of claim 7 , wherein the distal structure is an adsorbent pad which provides sufficient flow-through of the sample from the proximal end of the membrane to at least a control zone by capillary action.
9. The device of claim 1 , wherein the membrane further comprises a control zone having a control antibody bound thereto, wherein the control antibody is capable of binding with a detection reagent.
10. The device of claim 9 , wherein the control antibody is an anti-mouse IgG.
11. A method for determining whether a mammal is a PiZ gene carrier, the method comprising performing an immunochromatographic assay of a sample from the mammal to be tested, using the device of claim 3 , wherein the assay comprises:
binding of the Z-AAT protein to the capture antibody, and
detecting a complex that is formed between the capture antibody, the Z-AAT protein, and the detection reagent,
wherein detecting the complex indicates that the mammal is a PiZ carrier.
12. The method of claim 11 , wherein the PiZ carrier has a phenotype that is any allelic combination having a PiZ allele.
13. The method of claim 12 , wherein the phenotype is PiZZ, PiMZ, PiSZ, or PiZ/Null.
14. A kit comprising the device of claim 1 , wherein the detector antibody is labeled with a reporter moiety conjugated thereto.
15. A monoclonal antibody, or an antigen-binding fragment thereof, that specifically binds to Z-AAT protein, wherein the monoclonal antibody is produced by a hybridoma on deposit under an Accession Number selected from the group consisting of DSM ACC3092 (LG96) and DSM ACC3093 (MG97).
16. The monoclonal antibody of claim 15 produced by the hybridoma having Accession Number DSM ACC3092 (LG96), or an antigen-binding fragment thereof.
17. The monoclonal antibody of claim 15 produced by the hybridoma having Accession Number and DSM ACC3093 (MG97), or an antigen-binding fragment thereof.
18. The monoclonal antibody of or the antigen-binding fragment thereof of claim 15 , wherein the antibody or fragment is labeled.
19. A hybridoma cell line that produces a monoclonal antibody of claim 15 and is on deposit under an Accession Number selected from the group consisting of DSM ACC3092 (LG96) and DSM ACC3093 (MG97).
20. The hybridoma cell line of claim 17 deposited under ATCC Accession Number DSM ACC3092 (LG96).
21. The hybridoma cell line of claim 17 deposited under ATCC Accession Number DSM ACC3093 (MG97).